NEW YORK, July 6, 2020 /PRNewswire/ — Earlier last year, New York State voted to decriminalize the recreational use of cannabis. Instead of jail time, offenders are now punished with a fine. And while cannabis is only legal for medicinal purposes in the state of New York, many companies have already established […]
What Are the Benefits of CBD? The New York TimesSource: https://www.nytimes.com/2019/10/16/style/self-care/cbd-oil-benefits.html » Inline Ad Purchase: Intext Link
Zynerba’s CBD drug has failed its fourth trial in as many years. In a pivotal Phase III trial, their lead compound failed to significantly improve behavioral symptoms in patients with Fragile X syndrome, missing both the primary endpoint and three different secondary endpoints. The failure is the latest in a […]
Menthol cigarettes represent US $80 billion out of the US $814 billion global tobacco market, and a 36% share of the U.S. tobacco market alone. With menthol cigarette bans passed in jurisdictions to include Brazil, Canada, and the European Union, the Company has identified unmet demand that could continue to […]
All CBD oil contains trace amounts of compounds other than CBD. These compounds are found naturally in the hemp plant, from which the CBD is derived. They include CBC, CBG, and CBDA. Although very little research has been done into the possible benefits of these compounds, CBDA has been featured […]
It seems that just about everyone in the capital is taking CBD for just about everything at the moment. The more popular it becomes, the bigger the hype that surrounds it, with advocates recommending it as a treatment for everything from acne to cancer. Some have even been talking it […]
With the Federal Trade Commission (FTC) and the U.S. Food and Drug Administration (FDA) on high alert for unsubstantiated COVID-19 prevention or treatment claims, companies need to practice smart advertising now more than ever. Which companies have faced FTC and FDA regulatory action? What types of claims did they make? […]
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced top line results from the 14-week pivotal CONNECT-FX (Clinical study of Cannabidiol (CBD) in Children and Adolescents with Fragile X) trial. The multi-national, randomized, double-blind, placebo-controlled trial assessed the […]
click to enlarge This article was originally published on Best CBD Planet. To view the original article, click here. When it comes to the health and wellness industry, CBD has become the new buzzword for those looking to cash in on the cash crop that hemp has grown after the […]
Chronic obstructive pulmonary disease (COPD) may not be the most familiar sounding name for a health condition. And yet, it’s the third most common cause of death by disease in the United States. More than 15.3 million Americans suffer from COPD, a disease that often leads to a lowered quality […]
